Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Hims & Hers

< Previous 1 2 Next >
News headline image
Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Responds to FTC Lawsuit
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Announces Strategic Shift for US Weight Loss Business
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Continues Major International Expansion With Official Entry Into Canada
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology
From Hims & Hers
Via Business Wire
Tickers HIMS
News headline image
Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization
From Hims & Hers
Via Business Wire
Tickers HIMS
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.